Your browser doesn't support javascript.
loading
Safety of primary immunization using inactivated SARS-CoV-2 vaccine (CoronaVac®) among population aged 3 years and older in a large-scale use: A multi-center open-label study in China.
Yang, Haitao; Li, Zhen; Zhang, Ruizhi; Guo, Shicheng; Wang, Binbing; Fang, Xing; Zhang, Dongjuan; Zhang, Xiaoshu; Tong, Yeqing; Wang, Qing; Deng, Qiuyun; Sun, Zhaodan; Liu, Xiaoqiang; Gao, Yongjun.
Afiliación
  • Yang H; Yunnan Center for Disease Control and Prevention, China.
  • Li Z; Medical Affairs Department, Sinovac Life Sciences Co., Ltd, China.
  • Zhang R; Guizhou Center for Disease Control and Prevention, China.
  • Guo S; Jiangxi Center for Disease Control and Prevention, China.
  • Wang B; Anhui Center for Disease Control and Prevention, China.
  • Fang X; Liaoning Center for Disease Control and Prevention, China.
  • Zhang D; Fujian Center for Disease Control and Prevention, China.
  • Zhang X; Gansu Center for Disease Control and Prevention, China.
  • Tong Y; Hubei Center for Disease Control and Prevention, China.
  • Wang Q; Chongqing Center for Disease Control and Prevention, China.
  • Deng Q; Guangxi Center for Disease Control and Prevention, China.
  • Sun Z; Heilongjiang Center for Disease Control and Prevention, China.
  • Liu X; Yunnan Center for Disease Control and Prevention, China. Electronic address: lxq7611@126.com.
  • Gao Y; Medical Affairs Department, Sinovac Life Sciences Co., Ltd, China. Electronic address: gaoyj5737@sinovac.com.
Vaccine ; 41(7): 1354-1361, 2023 02 10.
Article en En | MEDLINE | ID: mdl-36658045

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / COVID-19 Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adolescent / Adult / Aged / Child / Humans Idioma: En Revista: Vaccine Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / COVID-19 Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adolescent / Adult / Aged / Child / Humans Idioma: En Revista: Vaccine Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Países Bajos